who shouldn't take glp 1 drugs Thinking of starting Ozempic, Wegovy, Saxenda, or Tirzepatide? 💉, These GLP-1 medications have become very popular for diabetes and weight loss—but they're not the right choice for everyone., In this Who Should Not Take GLP-1

Key Benefits: Tirzepatide (brand name Mounjaro) is a dual-action GLP-1 and GIP receptor agonist, providing an enhanced metabolic effect

Yang Y-A, Chong A, Song J (2018) Why is eradicating typhoid fever so challenging: implications for vaccine and therapeutic design

Research shows that GLP-1 medications slow gastric emptying and reduce nutrient absorption time in the small intestine, potentially lowering B12 levels by 10-15% over six to twelve months

Individual case reports or patient experiences may occasionally describe lymph node swelling during tirzepatide treatment, but such occurrences do not necessarily indicate causation